Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2019 16:15 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference

LEXINGTON, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...
September 25, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands

LEXINGTON, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...
September 24, 2019 07:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X Portfolio

LEXINGTON, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
September 19, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
September 11, 2019 09:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections

LEXINGTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
September 10, 2019 16:21 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract

Contract includes initial phase valued at $6 million, with a total value up to $69 million Call will also cover restructuring of CRG term loan agreement and Breakthrough Technology contract with...
September 10, 2019 16:14 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Restructuring of CRG Term Loan Agreement

LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...
September 10, 2019 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.

LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...
August 29, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the Janney Healthcare Conference 2019

LEXINGTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
August 16, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand

LEXINGTON, Mass., Aug. 16, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...